Evaluation of serum nestin levels for diagnosis and disease activity in lung cancer patients

Evaluation of serum nestin levels for diagnosis and disease activity in lung cancer patients - Evaluation of nestin in lung cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038228

Enrollment

120

Registered

2019-10-17

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with lung cacner at Nagoya City University Hospital. Patients with obtaining written informed consent.

Exclusion criteria

Exclusion criteria: Pregnant women and women with the possibility of pregnancy. Patients with other malignant tumors.

Design outcomes

Primary

Measure	Time frame
Relationship between serum nestin level and disease activigy in small cell lung cacner patients.	—

Secondary

Measure	Time frame
Evaluation of diagnostic significance of serum nestin level at the time of lung cancer diagnosis. Relationship between serum nestin levels and therapeutic response in small cell lung cancer.	—

Countries

Japan

Contacts

Public ContactKen Maeno

Nagoya City University Graduate School of Medical Sciences Respiratory Medicine, Allergy and Clinical Immunology

k.maeno@med.nagoya-cu.ac.jp0528538216

Outcome results